Latest Chemotherapy news
Multigene Signature Can Help Tailor Chemo for Operable Triple-Negative Breast Cancer
posted October 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
.jpg)
Restaging MRI Can Predict Survival With Rectal Cancer
posted October 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
.jpg)
FDA Approves Vyloy for Advanced Gastric or Gastroesophageal Junction Cancer
posted October 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
No Objective Improvement Seen in Cognitive Function With Exercise During Chemo
posted October 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors 
Dexrazoxane Offers Lasting Doxorubicin Cardioprotective Effect in Childhood Cancer Survivors 
AMH Predicts Benefit of Chemo + Endocrine Therapy in Under 55s With Breast Cancer Related Articles
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine 
KRAS ctDNA Linked to Worse Overall Survival in Localized Pancreatic Cancer 
Oral Drug Combo Effective for Older Patients With Acute Myeloid Leukemia .jpg)
Health Consequences Vary by Chemo Regimen in Testicular Cancer Survivors Monthly Specialist Briefings
Stay Connected
